DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Maertens JA, Raad II, Marr KA. , et al.
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Lancet 2016;
387 (10020): 760-769
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.